|
0
|
|
High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma.
(nature.com)
|
Pages-Geli C
…
Weiskopf K
Nature Communications
2026-08-01
|
#antibody
#immunotherapy
#lymphoma
#macrophage
#cytotoxicity
|
|
0
|
|
Establishment of germline-encoded antibodies during primary dengue infection.
(linkinghub.elsevier.com)
|
Verdonckt TW
…
Arien KK
Cell Reports
2026-08-01
|
#immunity
#antibody
#dengue
#repertoire
#vaccination
|
|
0
|
|
Immunobridging Analysis of Pemivibart for the Treatment of COVID-19: A Therapeutic Gap for the Immune-Compromised Population Remains.
(academic.oup.com)
|
Holmes A
…
Wingertzahn MA
Open Forum Infectious Diseases
2026-08-01
|
#covid-19
#antibody
#neutralization
#immunobridging
#immunocompromised
|
|
0
|
|
Growing up as an Immunologist Among Molecular Geneticists.
(onlinelibrary.wiley.com)
|
Rajewsky K
European Journal of Immunology
2026-08-01
|
#immunology
#antibody
#mutagenesis
#sequencing
|
|
0
|
|
Durability and Breadth of Neutralizing Antibodies Against SARS-CoV-2 Variants Following XBB.1.5 Vaccination in a Multiply Exposed Cohort.
(academic.oup.com)
|
Wang W
…
Weiss CD
Open Forum Infectious Diseases
2026-08-01
|
#vaccination
#immunity
#antibody
#covid-19
#variants
|
|
0
|
|
Durability of Respiratory Syncytial Virus Antibodies After Vaccination in Immunosuppressed Persons.
(academic.oup.com)
|
Nauroz Z
…
Karaba AH
Open Forum Infectious Diseases
2026-08-01
|
#immunosuppression
#vaccination
#antibody
#rsv
|
|
0
|
|
De novo epitope-specific antibody design via time-dependent guidance.
(academic.oup.com)
|
Kim Y
…
Baek M
Bioinformatics
2026-08-01
|
#antibody
#design
#epitope
#protein
#generative
|